Home > Article

Javelin Appoints Driscoll As CEO

By Associated Press

March 4, 2008

Recommended (0)

Drug developer Javelin Pharmaceuticals Inc. said Tuesday it appointed Martin J. Driscoll as the company's new chief executive.

Driscoll previously served as CEO of Pear Tree Pharmaceuticals Inc., a private pharmaceutical company that focuses on developing prescription products for women.

The company also said Daniel B. Carr will become vice chairman of the board. He will also continue to serve as chief medical officer.

Shares rose 30 cents, or 11.1 percent, to $3 in electronic after-hours trading. During regular trading, shares fell 16 cents, or 5.6 percent, to close at $2.70. The stock has traded in a 52-week range of $2.80 to $7.60.

Comment (0)

Recommended (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Be the first one to comment on this article.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Compare Brokers

DocumentId: 591205, ~/articles/articlehandler.aspx, 10/11/2008 12:35:32 AM,

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement